ResearcherFirst Affiliated Hospital Zhejiang UniversityNo recent work listed

Haiping Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7914-8782; OpenAlex author ID A5074014741. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2021.121176 ↗
New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment. Co-author DOI 10.1016/j.jconrel.2018.07.047 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Youqing Shen · 2 shared papers, 2018–2021 · strength 0.20
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176 ↗
- Paper New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment. DOI 10.1016/j.jconrel.2018.07.047 ↗
Xiangrui Liu · 2 shared papers, 2018–2021 · strength 0.20
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176 ↗
- Paper New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment. DOI 10.1016/j.jconrel.2018.07.047 ↗
Xiangsheng Liu · 1 shared paper, 2021 · strength 0.12
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176 ↗
Quan Zhou · 1 shared paper, 2021 · strength 0.12
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176 ↗
Liping Cao · 1 shared paper, 2021 · strength 0.12
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176 ↗
Liying Wang · 1 shared paper, 2021 · strength 0.12
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176 ↗
Huan Meng · 1 shared paper, 2021 · strength 0.12
- Paper Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer. DOI 10.1016/j.biomaterials.2021.121176 ↗
Lisong Teng · 1 shared paper, 2018 · strength 0.08
- Paper New path to treating pancreatic cancer: TRAIL gene delivery targeting the fibroblast-enriched tumor microenvironment. DOI 10.1016/j.jconrel.2018.07.047 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.